Form 4: Cognizant Director Abraham Schot Reports Acquisition of Restricted Stock Units Due to Dividend Equivalent Rights
SEC Form 4
Director Abraham Schot reports acquiring additional restricted stock units in Cognizant Technology Solutions Corp. due to dividend equivalent rights.
Summary
- Abraham Schot, a director of Cognizant Technology Solutions Corp., filed a Form 4 indicating changes in beneficial ownership.
- The report details the acquisition of restricted stock units (RSUs) as a result of dividend equivalent rights accrued on previously outstanding RSUs.
- On February 28, 2024, Schot acquired 2.3721 RSUs and 13.5801 RSUs, which are subject to the same terms as the original RSUs.
- These RSUs represent a contingent right to receive shares of Class A Common Stock of the company.
- The 2.3721 RSUs will vest fully on April 3, 2024, and the 13.5801 RSUs will vest fully on June 6, 2024.
- Following the reported transactions, Schot beneficially owns 622.9186 RSUs and 3,566.1584 RSUs directly.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and expected corporate governance practice. The sentiment is neutral to slightly positive as it reflects standard operating procedure.
Positives
- The acquisition of RSUs through dividend equivalent rights is a standard practice for compensating board members.
- The vesting schedules for the RSUs are clearly defined.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting dates of the RSUs.
Industry Context
Granting restricted stock units and dividend equivalent rights is a common practice in the technology industry to align the interests of board members with those of shareholders and to provide long-term incentives.
Comparison to Industry Standards
- Companies like Accenture, Infosys, and Tata Consultancy Services also use equity-based compensation for their board members.
- The specific terms of RSU grants and dividend equivalent rights can vary, but the underlying principle of aligning board member incentives with shareholder value is consistent across the industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Dividend Equivalent Rights Policy | The Board of Directors determined that all dividend equivalent rights on outstanding and any future restricted stock units granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms as the restricted stock units to which they relate. | September 7, 2023 | This policy ensures that non-employee board members receive the equivalent value of dividends paid on common stock, further aligning their interests with shareholders. |
Stakeholder Impact
- Shareholders are indirectly impacted as the compensation structure for board members is clarified.
- The policy ensures that non-employee board members receive the equivalent value of dividends paid on common stock, further aligning their interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| September 7, 2023 | Record date on or after which dividend equivalent rights apply to restricted stock units granted to non-employee board members. |
| February 28, 2024 | Date of transaction: acquisition of restricted stock units due to dividend equivalent rights. |
| April 3, 2024 | Vesting date for 2.3721 restricted stock units. |
| June 6, 2024 | Vesting date for 13.5801 restricted stock units. |
| March 01, 2024 | Date of report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.